S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
NASDAQ:DCTH

Delcath Systems (DCTH) Stock Price, News & Analysis

$4.87
+0.17 (+3.62%)
(As of 04/19/2024 ET)
Today's Range
$4.62
$4.90
50-Day Range
$3.72
$5.09
52-Week Range
$2.25
$7.99
Volume
301,598 shs
Average Volume
221,848 shs
Market Capitalization
$123.89 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.50

Delcath Systems MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
279.9% Upside
$18.50 Price Target
Short Interest
Bearish
3.68% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$100,001 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($1.45) to ($0.85) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.98 out of 5 stars

Medical Sector

366th out of 911 stocks

Surgical & Medical Instruments Industry

42nd out of 97 stocks

DCTH stock logo

About Delcath Systems Stock (NASDAQ:DCTH)

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

DCTH Stock Price History

DCTH Stock News Headlines

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.
Delcath Systems Appoints Martha Rook As COO
DCTH Apr 2024 7.500 call
Delcath Announces $7 Mln Private Placement
See More Headlines
Receive DCTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Delcath Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/26/2024
Today
4/19/2024
Next Earnings (Estimated)
5/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:DCTH
Employees
76
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$18.50
High Stock Price Target
$21.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+279.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-47,680,000.00
Net Margins
-2,308.86%
Pretax Margin
-2,308.86%

Debt

Sales & Book Value

Annual Sales
$2.07 million
Book Value
$0.72 per share

Miscellaneous

Free Float
20,071,000
Market Cap
$123.89 million
Optionable
Optionable
Beta
0.53
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Gerard J. Michel MBAMr. Gerard J. Michel MBA (Age 61)
    MS, CEO & Director
    Comp: $671.6k
  • Dr. Johnny John M.D. (Age 59)
    Senior Vice President of Clinical Operations & Medical Affairs
    Comp: $472.16k
  • Ms. Sandra Pennell (Age 45)
    Senior VP of Finance and Principal Financial & Accounting Officer
  • Dr. Martha S. Rook Ph.D. (Age 52)
    Chief Operating Officer
  • Mr. David Hoffman
    General Counsel, Corporate Secretary & Chief Compliance Officer
  • Dr. Vojislav Vukovic M.D. (Age 57)
    Ph.D., Chief Medical Officer

DCTH Stock Analysis - Frequently Asked Questions

Should I buy or sell Delcath Systems stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Delcath Systems in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" DCTH shares.
View DCTH analyst ratings
or view top-rated stocks.

What is Delcath Systems' stock price target for 2024?

4 analysts have issued 1 year price objectives for Delcath Systems' shares. Their DCTH share price targets range from $13.00 to $21.00. On average, they anticipate the company's share price to reach $18.50 in the next twelve months. This suggests a possible upside of 279.9% from the stock's current price.
View analysts price targets for DCTH
or view top-rated stocks among Wall Street analysts.

How have DCTH shares performed in 2024?

Delcath Systems' stock was trading at $4.16 at the beginning of 2024. Since then, DCTH stock has increased by 17.1% and is now trading at $4.87.
View the best growth stocks for 2024 here
.

When is Delcath Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 27th 2024.
View our DCTH earnings forecast
.

How were Delcath Systems' earnings last quarter?

Delcath Systems, Inc. (NASDAQ:DCTH) issued its quarterly earnings results on Tuesday, March, 26th. The company reported ($0.48) earnings per share for the quarter, beating the consensus estimate of ($0.67) by $0.19. The company earned $0.54 million during the quarter, compared to analyst estimates of $0.48 million. Delcath Systems had a negative net margin of 2,308.86% and a negative trailing twelve-month return on equity of 563.60%. During the same period last year, the business posted ($0.86) earnings per share.

When did Delcath Systems' stock split?

Delcath Systems shares reverse split on the morning of Tuesday, October 22nd 2019. The 1-100 reverse split was announced on Friday, October 18th 2019. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 21st 2019. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

How do I buy shares of Delcath Systems?

Shares of DCTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:DCTH) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners